Socma’s Bulk Pharmaceutical Task Force (BPTF) and European Chemical Industry Council’s Fine Chemicals Group (EFCG) are calling on the FDA to mandate inspections of non-US API manufacturing sites. The two organisations said the FDA should collect a fee for the cost of inspection and the maintenance of a database of inspected sites.
Socma
Thursday, 17 March 2011
Socma and EFCG call for FDA inspections
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment